Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-623
Closed -$216K 159
2024
Q1
$216K Sell
623
-2
-0.3% -$758 0.03% 149
2023
Q4
$286K Buy
625
+2
+0.3% +$986 0.04% 128
2023
Q3
$303K Hold
623
0.05% 124
2023
Q2
$279K Hold
623
0.04% 119
2023
Q1
$302K Hold
623
0.05% 115
2022
Q4
$319K Hold
623
0.05% 111
2022
Q3
$302K Hold
623
0.05% 109
2022
Q2
$292K Hold
623
0.05% 110
2022
Q1
$271K Hold
623
0.04% 115
2021
Q4
$289K Hold
623
0.04% 110
2021
Q3
$242K Hold
623
0.04% 116
2021
Q2
$276K Hold
623
0.04% 108
2021
Q1
$261K Hold
623
0.04% 114
2020
Q4
$256K Hold
623
0.05% 107
2020
Q3
$258K Hold
623
0.06% 100
2020
Q2
$242K Buy
+623
New +$233K 0.06% 107
2020
Q1
Sell
-623
Closed -$228K 112
2019
Q4
$228K Buy
+623
New +$198K 0.05% 110
2018
Q4
Sell
-623
Closed -$211K 114
2018
Q3
$211K Buy
+623
New +$202K 0.05% 105

Other funds holding HUM

Baxter Bros Inc's HUM Position: Q2 2024 in Review

Baxter Bros Inc sold out of Humana (HUM) in Q2 2024, closing a stake of 623 shares — an estimated $216K sold.

Baxter Bros Inc first reported a position in HUM in Q3 2018 and held it in 18 quarters. The position peaked at $319K in Q4 2022. 980 funds tracked by Wall St. Rank hold HUM as of Q2 2024.

  • Baxter Bros Inc reported no remaining Humana position as of Q2 2024 after selling out during the quarter.
  • Baxter Bros Inc sold 623 Humana shares in Q2 2024, an estimated $216K.
  • Baxter Bros Inc first reported a position in Humana in Q3 2018 and held it in 18 quarters.
  • Baxter Bros Inc's Humana position peaked at $319K in Q4 2022.
  • 980 funds tracked by Wall St. Rank held Humana as of Q2 2024.

Based on Baxter Bros Inc's 13F filing for Q2 2024, filed 15 Jul 2024.